# ALXO (Alx Oncology Holdings Inc.) - SEC EDGAR Financial Statements

> Alx Oncology Holdings Inc. reported $154.7M in total assets and a net loss of $80.57M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ALXO
- Markdown: https://convexityos.com/fundamentals/ALXO.md
- SEC CIK: 0001810182
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:46 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001810182&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$82.97M | Operating profit |
| Net Income | FY 2025 | -$80.57M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.57 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$68.61M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $147.2M | Total debt: $10.70M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $1.18M | $4.80M | $2.07M |
| Research & Development | $77.00M | $116.4M | $141.8M | $98.40M | $60.17M | $28.96M | $16.31M | $11.27M |
| Total Operating Expenses | $104.0M | $142.5M | $170.3M | $127.4M | $83.56M | $44.84M | $23.98M | $15.75M |
| **Operating Income** | -$104.0M | -$142.5M | -$170.3M | -$127.4M | -$83.56M | -$43.66M | -$19.18M | -$13.68M |
| **EBITDA** | -$103.3M | -$141.6M | -$169.4M | -$127.1M | -$83.50M | -$43.46M | -$18.75M | -$13.25M |
| Interest Income | $3.96M | $9.37M | $10.65M | $4.28M | $91K | -- | -- | -- |
| Interest Expense | $1.60M | $1.73M | $1.56M | $238K | $13K | -- | -- | -- |
| Income Before Tax | -$101.7M | -$134.8M | -$160.8M | -$123.4M | -$83.48M | -$45.50M | -$19.21M | -$13.69M |
| Income Tax Expense | $0 | $0 | $0 | $64K | -$21K | $241K | $34K | $45K |
| **Net Income** | -$101.7M | -$134.8M | -$160.8M | -$123.5M | -$83.46M | -$45.74M | -$19.24M | -$13.73M |
| Basic EPS | -$1.90 | -$2.58 | -$3.74 | -$3.03 | -$2.07 | -$2.76 | -$7.56 | -$6.33 |
| **Diluted EPS** | -$1.90 | -$2.58 | -$3.74 | -$3.03 | -$2.07 | -$2.76 | -$7.56 | -$6.33 |
| Basic Shares Outstanding | 53.7M | 52.2M | 43.0M | 40.7M | 40.3M | 18.5M | 3.1M | 2.8M |
| Diluted Shares Outstanding | 53.7M | 52.2M | 43.0M | 40.7M | 40.3M | 18.5M | 3.1M | 2.8M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $17.46M | $13.14M | $13.61M | $17.64M | $17.44M | $18.02M | $23.89M | $23.53M |
| Total Operating Expenses | $22.95M | $18.03M | $18.97M | $23.02M | $22.53M | $26.65M | $31.82M | $30.61M |
| **Operating Income** | -$22.95M | -$18.03M | -$18.97M | -$23.02M | -$22.53M | -$26.65M | -$31.82M | -$30.61M |
| **EBITDA** | -$22.89M | -$17.95M | -$18.82M | -$22.87M | -$22.38M | -$26.46M | -$31.61M | -$30.40M |
| Interest Income | $1.38M | $1.51M | $1.18M | $573K | $802K | $1.11M | $1.48M | $1.88M |
| Interest Expense | $225K | $285K | $331K | $383K | $408K | $405K | $406K | $427K |
| **Net Income** | -$21.83M | -$17.97M | -$17.93M | -$22.85M | -$22.14M | -$25.95M | -$30.75M | -$29.16M |
| Basic EPS | -$0.15 | -$0.13 | -$0.17 | -- | -$0.41 | -$0.49 | -$0.58 | -- |
| **Diluted EPS** | -$0.15 | -$0.13 | -$0.17 | -- | -$0.41 | -$0.49 | -$0.58 | -- |
| Basic Shares Outstanding | 140.9M | 135.6M | 104.6M | -- | 53.6M | 53.4M | 53.4M | -- |
| Diluted Shares Outstanding | 140.9M | 135.6M | 104.6M | -- | 53.6M | 53.4M | 53.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $16.37M | $17.57M | $22.41M | $48.82M | $363.7M | $434.2M | $9.02M |
| Short-Term Investments | $28.42M | $110.2M | $160.3M | $217.4M | -- | -- | -- |
| **Cash & Short-Term Investments** | $44.79M | $127.8M | $182.7M | $266.2M | $363.7M | $434.2M | $9.02M |
| Other Current Assets | $20K | $27K | $439K | -- | -- | -- | -- |
| **Total Current Assets** | $50.73M | $134.4M | $188.7M | $271.0M | $367.0M | $436.0M | $9.81M |
| Property, Plant & Equipment, Net | $1.20M | $2.90M | $3.59M | $3.89M | $897K | $52K | $860K |
| Long-Term Investments | $3.49M | $3.52M | $35.41M | $16.70M | -- | -- | -- |
| Other Non-Current Assets | $3.62M | $6.99M | $14.89M | $14.93M | $12.27M | $10K | $7.0K |
| **Total Non-Current Assets** | $8.32M | $13.42M | $53.89M | $35.52M | $13.16M | $62K | $867K |
| **Total Assets** | $59.05M | $147.8M | $242.6M | $306.5M | $380.2M | $436.1M | $10.68M |
| Accounts Payable | $4.91M | $4.50M | $8.59M | $8.07M | $3.76M | $4.0K | $3.75M |
| Short-Term Debt | $5.22M | $435K | $0 | $0 | -- | -- | -- |
| Other Current Liabilities | $0 | $149K | $543K | $1.65M | -- | -- | -- |
| **Total Current Liabilities** | $24.55M | $18.50M | $36.00M | $28.32M | $15.29M | $6.20M | $4.98M |
| Long-Term Debt | $4.53M | $9.47M | $9.64M | $9.39M | -- | -- | $5.42M |
| Other Non-Current Liabilities | $3.98M | $6.19M | $7.20M | $5.31M | $1.84M | $5.0K | $547K |
| **Total Non-Current Liabilities** | $8.51M | $15.66M | $16.84M | $14.70M | $1.84M | $5.0K | $5.97M |
| **Total Liabilities** | $33.06M | $34.16M | $52.84M | $43.02M | $17.13M | $6.21M | $10.95M |
| **Total Debt (incl. Leases)** | $14.77M | $16.98M | $17.20M | $15.70M | $2.72M | -- | $5.42M |
| Common Stock | $54K | $53K | $50K | $41K | $41K | $40K | $3.0K |
| Retained Earnings | -$722.8M | -$621.1M | -$486.3M | -$325.5M | -$202.0M | -$118.5M | -$72.78M |
| Accumulated Other Comp. Income | $28K | $275K | $256K | -$845K | -- | -- | -- |
| **Total Stockholders' Equity** | $25.98M | $113.6M | $189.7M | $263.5M | $363.0M | $429.8M | -$70.64M |
| Total Equity | $25.98M | $113.6M | $189.7M | $263.5M | $363.0M | $429.8M | -$70.64M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $35.45M | $22.69M | $32.28M | $16.37M | $23.44M | $19.30M | $20.61M | $17.57M |
| Short-Term Investments | $111.8M | $115.5M | $108.0M | $28.42M | $37.18M | $60.01M | $77.22M | $110.2M |
| **Cash & Short-Term Investments** | $147.2M | $138.2M | $140.3M | $44.79M | $60.63M | $79.31M | $97.83M | $127.8M |
| Other Current Assets | $132K | $542K | $25K | $20K | -- | $4.0K | -- | $27K |
| **Total Current Assets** | $152.9M | $143.5M | $145.6M | $50.73M | $66.52M | $85.26M | $102.5M | $134.4M |
| Property, Plant & Equipment, Net | $149K | $166K | $1.05M | $1.20M | $1.35M | $1.50M | $2.70M | $2.90M |
| Long-Term Investments | $0 | $15.15M | $28.78M | $3.49M | $5.84M | $4.23M | $9.16M | $3.52M |
| Other Non-Current Assets | $1.66M | $2.05M | $2.93M | $3.62M | $9.02M | $4.33M | $6.50M | $6.99M |
| **Total Non-Current Assets** | $1.80M | $17.36M | $32.76M | $8.32M | $16.21M | $10.06M | $18.37M | $13.42M |
| **Total Assets** | $154.7M | $160.8M | $178.3M | $59.05M | $82.72M | $95.32M | $120.9M | $147.8M |
| Accounts Payable | $3.99M | $3.02M | $3.85M | $4.91M | $6.58M | $4.90M | $3.94M | $4.50M |
| Short-Term Debt | $0 | $0 | $5.22M | $5.22M | $4.35M | $3.04M | $1.74M | $435K |
| Other Current Liabilities | -- | -- | -- | $0 | $0 | $40K | $48K | $149K |
| **Total Current Liabilities** | $19.02M | $14.78M | $20.18M | $24.55M | $27.72M | $18.85M | $18.74M | $18.50M |
| Long-Term Debt | $9.74M | $9.71M | $3.29M | $4.53M | $5.76M | $7.00M | $8.23M | $9.47M |
| Other Non-Current Liabilities | $64K | $152K | $3.51M | $3.98M | $4.44M | $5.06M | $5.63M | $6.19M |
| **Total Non-Current Liabilities** | $9.80M | $9.86M | $6.80M | $8.51M | $10.20M | $12.06M | $13.86M | $15.66M |
| **Total Liabilities** | $28.82M | $24.63M | $26.98M | $33.06M | $37.92M | $30.91M | $32.60M | $34.16M |
| **Total Debt (incl. Leases)** | $10.70M | $11.04M | $13.05M | $14.77M | $15.61M | $16.18M | $16.59M | $16.98M |
| Common Stock | $143K | $138K | $135K | $54K | $54K | $54K | $53K | $53K |
| Retained Earnings | -$780.5M | -$758.7M | -$740.7M | -$722.8M | -$700.0M | -$677.8M | -$651.9M | -$621.1M |
| Accumulated Other Comp. Income | -$259K | -$224K | -$245K | $28K | $43K | $36K | $118K | $275K |
| **Total Stockholders' Equity** | $125.9M | $136.2M | $151.3M | $25.98M | $44.80M | $64.42M | $88.30M | $113.6M |
| Total Equity | $125.9M | $136.2M | $151.3M | $25.98M | $44.80M | $64.42M | $88.30M | $113.6M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$101.7M | -$134.8M | -$160.8M | -$123.5M | -$83.46M | -$45.74M | -$19.24M | -$13.73M |
| Depreciation & Amortization | $706K | $872K | $836K | $342K | $51K | $202K | $429K | $431K |
| Stock-Based Compensation | $12.58M | $27.09M | $26.27M | $23.84M | $13.91M | $5.44M | $297K | $269K |
| Change in Payables | $421K | -$4.02M | $458K | $4.51M | $3.29M | -$3.74M | $2.98M | -$269K |
| **Operating Cash Flow** | -$84.14M | -$121.9M | -$130.4M | -$89.22M | -$68.10M | -$38.29M | -$14.25M | -$13.19M |
| Capital Expenditure | -$212K | -$447K | -$1.27M | -$1.43M | -$666K | -$31K | -$353K | -$653K |
| **Free Cash Flow** | -$84.35M | -$122.4M | -$131.6M | -$90.65M | -$68.77M | -$38.32M | -$14.60M | -$13.84M |
| Purchases of Investments | -$51.59M | -$107.4M | -$246.6M | -$376.8M | -- | -- | -- | -- |
| **Investing Cash Flow** | $82.59M | $86.26M | $44.66M | -$235.4M | -$4.92M | $610K | -$353K | -$653K |
| Common Stock Issued | $1.69M | $29.66M | -- | -- | -- | $368.3M | -- | -- |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$6.0K |
| **Financing Cash Flow** | $362K | $30.82M | $59.29M | $9.86M | $2.47M | $462.9M | $15.36M | $1.0K |
| **Net Change in Cash** | -$1.19M | -$4.84M | -$26.42M | -$314.8M | -$70.55M | $425.2M | $755K | -$13.84M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.83M | -$17.97M | -$17.93M | -$22.85M | -$22.14M | -$25.95M | -$30.75M | -$29.16M |
| Depreciation & Amortization | $56K | $86K | $150K | $151K | $153K | $191K | $211K | $214K |
| Stock-Based Compensation | $2.89M | $2.68M | $2.51M | $2.71M | $2.52M | $2.14M | $5.22M | $5.86M |
| Change in Payables | $1.05M | -$765K | -$1.21M | -$1.67M | $1.68M | $965K | -$556K | -$3.39M |
| **Operating Cash Flow** | -$14.74M | -$16.06M | -$18.65M | -$18.98M | -$17.09M | -$23.41M | -$24.66M | -$32.05M |
| Capital Expenditure | -$65K | -$17K | -$50K | -$49K | -$56K | -$47K | -$60K | -$60K |
| **Free Cash Flow** | -$14.80M | -$16.07M | -$18.70M | -$19.03M | -$17.15M | -$23.45M | -$24.72M | -$32.11M |
| Purchases of Investments | -$25.05M | -$5.75M | -$124.5M | -$5.97M | -$4.44M | -$25.40M | -$15.78M | -$4.44M |
| **Investing Cash Flow** | $19.24M | $6.52M | -$105.0M | $11.23M | $21.39M | $22.32M | $27.64M | $33.18M |
| Common Stock Issued | $8.54M | $0 | $11K | $1.32M | $0 | $0 | $372K | $359K |
| **Financing Cash Flow** | $8.20M | $137K | $139.6M | $678K | -$159K | -$222K | $65K | $328K |
| **Net Change in Cash** | $12.70M | -$9.40M | $15.91M | -$7.07M | $4.14M | -$1.31M | $3.05M | $1.47M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -3694.0% | -400.0% | -662.0% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -3869.7% | -401.2% | -664.3% |
| Return on Equity (ROE) | -391.4% | -118.7% | -84.8% | -46.9% | -23.0% | -10.6% | -- | -- |
| Return on Assets (ROA) | -172.2% | -91.3% | -66.3% | -40.3% | -22.0% | -10.5% | -180.2% | -- |
| Current Ratio | 2.07x | 7.26x | 5.24x | 9.57x | 24.00x | 70.28x | 1.97x | -- |
| Quick Ratio | 1.82x | 6.91x | 5.08x | 9.40x | 23.78x | 69.99x | 1.81x | -- |
| Debt to Equity | 0.57x | 0.15x | 0.09x | 0.06x | 0.01x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -75.4% | +132.0% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -64.0% | -59.4% | -58.7% | -391.4% | -241.1% | -181.0% | -147.3% | -118.7% |
| Return on Assets (ROA) | -52.1% | -50.3% | -49.8% | -172.2% | -130.6% | -122.3% | -107.5% | -91.3% |
| Current Ratio | 8.04x | 9.71x | 7.21x | 2.07x | 2.40x | 4.52x | 5.47x | 7.26x |
| Quick Ratio | 7.74x | 9.35x | 6.95x | 1.82x | 2.19x | 4.21x | 5.22x | 6.91x |
| Debt to Equity | 0.09x | 0.08x | 0.09x | 0.57x | 0.35x | 0.25x | 0.19x | 0.15x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
